DIEP皮瓣乳房再造术后静脉血栓栓塞:术后预防方案实施后的结局回顾
该研究回顾性分析2014年1月至2020年3月在本机构接受DIEP皮瓣乳房再造的患者,比较2019年3月起实施的术后2周依诺肝素预防方案(不论危险因素)与未预防者的结局。结果显示未预防出院者VTE风险显著更高(3.7% vs 0%,P=0.03),Caprini评分≥6分者VTE风险高25倍(P=0.0002),方案未增加血肿并发症。
要点
- 未预防出院者VTE发生率3.7%,预防组0%,差异有统计学意义(P=0.03)。
- Caprini评分≥6分者VTE风险高25倍(P=0.0002)。
- 2周依诺肝素方案未影响血肿并发症发生率。
核心结论
- 作者证明在DIEP皮瓣乳房再造患者中成功实施2周VTE化学预防方案,显著降低VTE发生率且不影响血肿并发症发生率。
研究设计与样本
- 回顾性病历审查,纳入作者所在机构2014年1月至2020年3月所有接受DIEP皮瓣乳房再造的患者,按术后是否纳入2019年3月起实施的新VTE预防方案(2周依诺肝素治疗,不论患者危险因素)分组,记录人口学、预防类型和结局数据。
主要发现
- 未接受VTE预防出院者VTE风险显著高于接受预防出院者(3.7% vs 0%;P=0.03)。
- VTE预防组无一例发生深静脉血栓或肺栓塞。
- Caprini评分大于或等于6分的患者发生VTE事件的风险高25倍(P=0.0002)。
关键数值与推荐
- VTE预防方案为2周依诺肝素治疗,不论患者危险因素。
- 未预防出院者VTE发生率3.7%,预防出院者0%(P=0.03)。
- Caprini评分≥6分者VTE风险高25倍(P=0.0002)。
临床怎么用
- 作者实施并证明2周依诺肝素VTE化学预防方案在DIEP皮瓣乳房再造患者中可显著降低VTE发生率且不影响血肿并发症发生率。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Deep inferior epigastric perforator (DIEP) flap breast reconstruction is among the higher-risk patient groups for venous thromboembolism (VTE) in plastic surgery. Surgeons often opt for a patient-specific approach to postoperative anticoagulation, and the field has yet to come to a consensus on VTE chemoprophylaxis regimens. METHODS: A new chemoprophylaxis protocol was introduced starting in March of 2019 that involved 2 weeks of treatment with enoxaparin, regardless of patient risk factors. A retrospective chart review was conducted on all patients who underwent DIEP flap breast reconstruction at the authors' institution between January of 2014 and March of 2020. Patients were grouped based on whether they enrolled in the new VTE protocol in the postoperative period or not. Patient demographics, prophylaxis type, and outcomes data were recorded, retrospectively. The primary outcome measure was postoperative VTE incidence. RESULTS: Risk of VTE was significantly higher in patients discharged without VTE prophylaxis compared with patients discharged with prophylaxis (3.7% versus 0%; P = 0.03). Notably, zero patients in the VTE prophylaxis group developed a deep venous thrombosis or pulmonary embolism. In addition, the risk of a VTE event was 25 times greater in patients with a Caprini score greater than or equal to 6 ( P = 0.0002). CONCLUSION: The authors demonstrate the successful implementation of a 2-week VTE chemoprophylaxis protocol in DIEP flap breast reconstruction patients that significantly reduces the rate of VTE while not affecting the rate of hematoma complications. CLINICAL QUESTION/LEVEL OF EVIDENCE: Therapeutic, III.
引用
- Tuaño KR, Yang JH, Fisher MH, et al. Venous Thromboembolism after DIEP Flap Breast Reconstruction: Review of Outcomes after a Postoperative Prophylaxis Protocol. Plast Reconstr Surg. 2023. PMID: 37506353. doi:10.1097/PRS.0000000000010949
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。